Moreover, the efficacy of the anticancer drug, cisplatin was not altered significantly by 3 μM of GS-9973 in the parental and resistant cancer cells proving that cisplatin is not an ABCG2 specific substrate which is consistent with the previous studies. This evidence concerns the gene ABCG2 and cancer.